Skip to main content
logo
Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.260
+0.050 (4.13%)
At close: Jul 2, 2026, 4:00 PM EDT
1.240
-0.020 (-1.59%)
After-hours: Jul 2, 2026, 7:06 PM EDT

Metagenomi Therapeutics Revenue

Metagenomi Therapeutics had revenue of $1.25M in the quarter ending March 31, 2026, a decrease of -69.76%. This brings the company's revenue in the last twelve months to $22.33M, down -50.66% year-over-year. In the year 2025, Metagenomi Therapeutics had annual revenue of $25.21M, down -51.79%.

Revenue (ttm)
$22.33M
Revenue Growth
-50.66%
P/S Ratio
2.12
Revenue / Employee
$189,246
Employees
118
Market Cap
47.44M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202525.21M-27.09M-51.79%
Dec 31, 202452.30M7.54M16.84%
Dec 31, 202344.76M27.56M160.21%
Dec 31, 202217.20M16.96M6,978.19%
Dec 31, 2021243.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veru Inc.16.89M
Radiopharm Theranostics10.86M
CervoMed2.09M
Hyperion DeFi1.04M
ABVC BioPharma797.92K
INmune Bio50.00K
Impact BioMedical39.00K
Revenue Rankings

MGX News

More News